Companies

TriReme Medical has signed a broad distribution agreement with J&J’s Cordis Corporation for the exclusive distribution of the Chocolate PTA balloon catheter, with an option for additional TriReme portfolio products.

Medtronic is launching its tiny Reveal LINQ heart monitor globally following U.S. FDA and Euroepan CE mark clearance. The Reveal LINQ Insertable Cardiac Monitor (ICM) System is a five times smaller than the previous smallest implantable cardiac monitoring device

Device household name Stryker spreads its wings far beyond Orthopaedics these days, as evidenced with its newly announced acquisition of German surgical equipment maker Berchtold Holding, AG for an enterprise value of $172 million.

Some solid revenue growth for Medtronic, compared with the same quarter a year ago, were somewhat spoiled by a $200 million write down following the poor outcome from its much vaunted Symplicity HTN-3 Study.

Boston Scientific Corporation has received CE Mark approval for its WallFlex™ Esophageal Fully Covered Stent to treat refractory benign esophageal strictures.

Atrial Fibrillation raises stroke risk five-fold. But it’s often asymptomatic and paroxysmal, leaving patients with a risk they either know nothing about or that medial professionals can’t detect. Medtronic’s monitoring solution has now been found to outperform the current standard of care, raising the possibility of reducing incidence of cryptogenic stroke.

Medtronic has initiated the European launch of the TOTAL across crossing catheter, which recently received the CE Mark as a tool for improving blood flow through narrowed or occluded lower-extremity arteries, including those in the especially challenging below-the-knee (BTK) vessel bed.

Cook Medical’s EchoTip® ProCore™ Endobronchial Ultrasound Needle gives physicians the ability to retrieve both cell and tissue samples from lymph nodes or tumors in the pulmonary area.

Sorin’s financials for 2013 look pretty punchy and despite a few product-lifecycle challenges appear to indicate that the financial impact of the recent earthquake experienced at one of the company’s facilities are well behind it.

St. Jude Medical, Inc. has announced the first U.S. implant in the company’s LEADLESS II pivotal trial designed to evaluate the Nanostim™ leadless pacemaker on its way to U.S. FDA approval.

A new agreement with LifeNet Health sees DePuy Synthes Spine adding cellular allograft products to its growing portfolio of allograft implants.

Zimmer Spine’s flexible, cancellous bone allografts are used in spine surgery, either alone or as a bone graft extender to stimulate natural bone formation processes. New configurations make life easier for surgeons by reducing the need for shaping during procedures.

Biomet, Inc. has reached a settlement amounting to $56 million in Multi-District Litigation (MDL) 2391 relating to its M2A Magnum Hip Implant Products.

Putting a few troubled years behind it, US Sports med, Spine and ENT device maker ArthroCare has been acquired by Smith and Nephew in a deal that values the Austin, Texas outfit at $1.7 Billion.

Wright Medical Group, Inc. has acquired Solana Surgical, LLC and entered into a definitive agreement to acquire OrthoPro, LLC (OrthoPro), both of which it describes as privately held, high growth extremity companies.

J&J Subsidiary, Cordis Corporation has seen two-year data from its INNOVATION Trial presented at the 2014 Leipzig Interventional Course in Germany. Data from the study continues to demonstrate that the INCRAFT® System performs well in patients suffering from abdominal aortic aneurysms (AAA) two years after treatment.